Hidden among the crowd: Differential DNA methylation-expression correlations in cancer occur at important oncogenic pathways

Frontiers in Genetics

Volumn 6, Issue MAY, 2015, Pages

  Orgueira, Adrián Mosquera ^a  

^a NONE   (Spain)

Author keywords

Cancer; DNA methylation; Gene expression

Indexed keywords

HISTONE H3; MICRORNA; POLYCOMB REPRESSIVE COMPLEX 2;

ARTICLE; BREAST CANCER; CHROMATIN; CONTROLLED STUDY; COPY NUMBER VARIATION; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE ONTOLOGY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; NEOPLASM; ONCOGENE; TRANSCRIPTION INITIATION SITE; X CHROMOSOME;

EID: 84940106183     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2015.00163     Document Type: Article

References (81)

1. Abelson, P. R. (1995). Statistics as Principled Argument. New York, NY: Taylor & Francis Group.
2. Agarwal, T., Roy, S., Kumar, S., Chakraborty, T. K., and Maiti, S. (2014). In the sense of transcription regulation by G-quadruplexes: asymmetric effects in sense and antisense strands. Biochemistry 53, 3711-3718. doi: 10.1021/bi401451q.
3. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., et al. (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29. doi: 10.1038/75556.
4. Bae, W. K., Yoo, K. H., Lee, J. S., Kim, Y., Chung, I. J., Park, M. H., et al. (2014). The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers. Mol. Carcinog. doi: 10.1002/mc.22188. [Epub ahead of print].
5. Barrett, T., Wilhite, S. E., Ledoux, P., Evangelista, C., Kim, I. F., Tomashevsky, M., et al. (2013). NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 41, D991-D995. doi: 10.1093/nar/gks1193.
6. Bell, J. T., Pai, A. A., Pickrell, J. K., Gaffney, D. J., Pique-Regi, R., Degner, J. F., et al. (2011). DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol. 12, R10. doi: 10.1186/gb-2011-12-1-r10.
7. Berman, B. P., Weisenberger, D. J., Aman, J. F., Hinoue, T., Ramjan, Z., Liu, Y., et al. (2011). Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat. Genet. 44, 40-46. doi: 10.1038/ng.969.
8. Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., et al. (2010). The landscape of somatic copy-number alteration across human cancers. Nature 463, 899-905. doi: 10.1038/nature08822.
9. Blumenthal, R. D., Hansen, H. J., and Goldenberg, D. M. (2005). Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Cancer Res. 65, 8809-8817. doi: 10.1158/0008-5472.CAN-05-0420.
10. Bork, S., Pfister, S., Witt, H., Horn, P., Korn, B., Ho, A. D., et al. (2010). DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9, 54-63. doi: 10.1111/j.1474-9726.2009.00535.x.
11. Boros, J., Arnoult, N., Stroobant, V., Collet, J. F., and Decottignies, A. (2014). Polycomb Repressive Complex 2 and H3K27me3 cooperate with H3K9 methylation to maintain Heterochromatin Protein 1a at chromatin. Mol. Cell. Biol. 34, 3662-3674. doi: 10.1128/MCB.00205-14.
12. Brenet, F., Moh, M., Funk, P., Feierstein, E., Viale, A. J., Socci, N. D., et al. (2011). DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS ONE 6:e14524. doi: 10.1371/journal.pone.0014524.
13. Cerami, E. G., Gross, B. E., Demir, E., Rodchenkov, I., Babur, O., Anwar, N., et al. (2011). Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res. 39, D685-D690. doi: 10.1093/nar/gkq1039.
14. Chaffer, C. L., Marjanovic, N. D., Lee, T., Bell, G., Kleer, C. G., Reinhardt, F., et al. (2013). Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154, 61-74. doi: 10.1016/j.cell.2013.06.005.
15. Creelan, B. C., Antonia, S., Noyes, D., Hunter, T. B., Simon, G. R., Bepler, G., et al. (2013). Phase II trial of a GM-CSF-producing and CD40L-expressing bystander cell line combined with an allogeneic tumor cell-based vaccine for refractory lung adenocarcinoma. J. Immunother. 36, 442-450. doi: 10.1097/CJI.0b013e3182a80237.
16. Doi, A., Park, I. H., Wen, B., Murakami, P., Aryee, M. J., Irizarry, R., et al. (2009). Differential methylation of tissue-and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41, 1350-1353. doi: 10.1038/ng.471.
17. Durinck, S., Spellman, T. P., Birney, E., and Huber, W. (2009). Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat. Protoc. 4, 1184-1191. doi: 10.1038/nprot.2009.97.
18. ENCODE Project Consortium. (2012). An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74. doi: 10.1038/nature11247.
19. Fertig, E. J., Markovic, A., Danilova, L. V., Gaykalova, D. A., Cope, L., Chung, C. H., et al. (2013). Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis. PLoS ONE 8:e78127. doi: 10.1371/journal.pone.0078127.
20. Ghavifekr, F. M., Farshdousti, H. M., Shanehbandi, D., and Baradaran, B. (2014). DNA methylation pattern as important epigenetic criterion in cancer. Genet. Res. Int. 2013:317569. doi: 10.1155/2013/317569.
21. Gieni, R. S., and Hendzel, M. J. (2009). Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer. Biochem. Cell Biol. 87, 711-746. doi: 10.1139/O09-057.
22. Gonzalez, M. E., Moore, H. M., Li, X., Toy, K. A., Huang, W., Sabel, M. S., et al. (2014). EZH2 expands breast stem cells through activation of NOTCH1 signaling. Proc. Natl. Acad. Sci. U.S.A. 111, 3098-3103. doi: 10.1073/pnas.1308953111.
23. Goodwin, D. L., and Leech, L. L. (2006). Understanding correlation. Factors that affect the size of r. J. Exp. Educ. 74, 251-266. doi: 10.3200/JEXE.74.3.249-266.
24. Govindan, S. V., Cardillo, T. M., Moon, S. J., Hansen, H. J., and Goldenberg, D. M. (2009). CEACAM5-targeted therapy of human colonic and pancreatic cancer xenografts with potent labetuzumab-SN-38 immunoconjugates. Clin. Cancer Res. 15, 6052-6061. doi: 10.1158/1078-0432.CCR-09-0586.
25. Guibert, S., Zhao, Z., Sjölinder, M., Göndör, A., Fernandez, A., Pant, V., et al. (2012). CTCF-binding sites within the H19 ICR differentially regulate local chromatin structures and cis-acting functions. Epigenetics 7, 361-369. doi: 10.4161/epi.19487.
26. Guillaumet-Adkins, A., Richter, J., Odero, M. D., Sandoval, J., Agirre, X., Catala, A., et al. (2014). Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels. J. Hematol. Oncol. 7, 4. doi: 10.1186/1756-8722-7-4.
27. Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., et al. (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076. doi: 10.1038/nature08975.
28. Halder, R., Halder, K., Sharma, P., Garg, G., Sengupta, S., and Chowdhury, S. (2010). Guanine quadruplex DNA structure restricts methylation of CpG dinucleotides genome-wide. Mol. Biosyst. 6, 2439-2447. doi: 10.1039/c0mb00009d.
29. Han, H., Cortez, C. C., Yang, X., Nichols, P. W., Jones, P. A., and Liang, G. (2011). DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter. Hum. Mol. Genet. 20, 4299-4310. doi: 10.1093/hmg/ddr356.
30. Hansen, K. D., Timp, W., Bravo, H. C., Sabunciyan, S., Langmead, B., McDonald, O. G., et al. (2011). Increased methylation variation in epigenetic domains across cancer types. Nat. Genet. 43, 768-75. doi: 10.1038/ng.865.
31. Holm, T. M., Jackson-Grusby, L., Brambrink, T., Yamada, Y., Rideout, W. M., et al. (2005). Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8, 275-285. doi: 10.1016/j.ccr.2005.09.007.
32. Hon, G. C., Hawkins, R. D., Caballero, O. L., Lo, C., Lister, R., Pelizzola, M., et al. (2012). Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res. 2, 246-258. doi: 10.1101/gr.125872.111.
33. Houseman, E. A., Christensen, B. C., Karagas, M. R., Wrensch, M. R., Nelson, H. H., Wiemels, J. L., et al. (2009). Copy number variation has little impact on bead-array-based measures of DNA methylation. Bioinformatics 25, 1999-2005. doi: 10.1093/bioinformatics/btp364.
34. Huang, T. H., Yeh, P. L., Martin, M. B., Straub, R. E., Gilliam, T. C., Caldwell, C. W., et al. (1995). Genetic alterations of microsatellites on chromosome 18 in human breast carcinoma. Diagn. Mol. Pathol. 4, 66-72. doi: 10.1097/00019606-199503000-00012.
35. Huppert, J. L., and Balasubramanian, S. (2007). G-quadruplexes in promoters throughout the human genome. Nucleic Acids Res. 35, 406-413. doi: 10.1093/nar/gkl1057.
36. Jirtle, L. J. (1997). Geneimprint. Geneimprint database. Available online at: http://www.geneimprint.com/site/genes-by-species.
37. Jjingo, D., Conley, A. B., Yi, S. V., Lunyak, V. V., and Jordan, I. K. (2012). On the presence and role of human gene-body DNA methylation. Oncotarget 3, 462-474.
38. Johnson, W. E., Li, C., and Rabinovic, A. (2007). Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127. doi: 10.1093/biostatistics/kxj037.
39. Jones, P., Binns, D., Chang, H. Y., Fraser, M., Li, W., McAnulla, C., et al. (2014). InterProScan 5: genome-scale protein function classification. Bioinformatics 30, 1236-1240. doi: 10.1093/bioinformatics/btu031.
40. Kanduri, M., Sander, B., Ntoufa, S., Papakonstantinou, N., Sutton, L. A., Stamatopoulos, K., et al. (2013). A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma. Epigenetics 8, 1280-1288. doi: 10.4161/epi.26546.
41. Kanehisa, M. (2013). Molecular network analysis of diseases and drugs in KEGG. Methods Mol. Biol. 939, 263-275. doi: 10.1007/978-1-62703-107-3_17.
42. Kemp, C. J., Moore, J. M., Moser, R., Bernard, B., Teater, M., Smith, L. E., et al. (2014). CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancer. Cell Rep. 7, 1020-1029. doi: 10.1016/j.celrep.2014.04.004.
43. Kim, Y. J., Yoon, H. Y., Kim, J. S., Kang, H. W., Min, B. D., Kim, S. K., et al. (2013). HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling. Int. J. Cancer 133, 1135-1142. doi: 10.1002/ijc.28121.
44. Klipp, E. (2009). Systems Biology: A Textbook. Weinheim: Wiley-VCH.
45. Kresse, S. H., Rydbeck, H., Skårn, M., Namløs, H. M., Barragan-Polania, A. H., Cleton-Jansen, A. M., et al. (2012). Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma. PLoS ONE 7:e48262. doi: 10.1371/journal.pone.0048262.
46. Li, T., Chen, H., Li, W., Cui, J., Wang, G., Hu, X., et al. (2014). Promoter histone H3K27 methylation in the control of IGF2 imprinting in human tumor cell lines. Hum. Mol. Genet. 23, 117-128. doi: 10.1093/hmg/ddt405.
47. Liu, Q., Yang, B., Xie, X., Wei, L., Liu, W., Yang, W., et al. (2014). Vigilin interacts with CCCTC-binding factor (CTCF) and is involved in CTCF-dependent regulation of the imprinted genes Igf2 and H19. FEBS J. 281, 2713-2725. doi: 10.1111/febs.12816.
48. Liu, Z. G., Lei, Y. Y., Li, W. W., and Chen, Z. G. (2013). The co-expression of ERβ2 and IL-12Rβ2 is better prognostic factor in non-small-cell lung cancer progression. Med. Oncol. 30, 592. doi: 10.1007/s12032-013-0592-x.
49. Lou, S., Lee, H. M., Qin, H., Li, J. W., Gao, Z., Liu, X., et al. (2014). Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation. Genome Biol. 15, 408. doi: 10.1186/s13059-014-0408-0.
50. McEntyre, J., and Lipman, D. (2001). PubMed: bridging the information gap. CMAJ 164, 1317-1319.
51. Moran, A. E., Kovacsovics-Bankowski, M., and Weinberg, A. D. (2013). The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy. Curr. Opin. Immunol. 25, 230-237. doi: 10.1016/j.coi.2013.01.004.
52. Morey, L., and Helin, K. (2010). Polycomb group protein-mediated repression of transcription. Trends Biochem. Sci. 35, 323-332. doi: 10.1016/j.tibs.2010.02.009.
53. Mudholkar, G. S. (2006). "Fisher's Z-Transformation," in Encyclopedia of Statistical Sciences, eds S. Kotz, C. B. Read, N. Balakrishnan, and B. Vidakovic (New York, NY: Wiley Online).
54. Myers, L., and Sirois, M. J. (2006). "Differences between Spearman Correlation Coefficients," in Encyclopedia of Statistical Sciences (John Wiley & Sons, Inc.), 12.
55. R Core Team (2012). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Avaliable online at: http://www.R-project.org/.
56. Rakhmilevich, A. L., Alderson, K. L., and Sondel, P. M. (2012). T-cell-independent antitumor effects of CD40 ligation. Int. Rev. Immunol. 31, 267-278. doi: 10.3109/08830185.2012.698337.
57. Sandoval, J., Heyn, H., Moran, S., Serra-Musach, J., Pujana, M. A., Bibikova, M., et al. (2011). Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 6, 692-702. doi: 10.4161/epi.6.6.16196.
58. Sandve, G. K., Gundersen, S., Rydbeck, H., Glad, I. K., Holden, L., Holden, M., et al. (2010). The Genomic HyperBrowser: inferential genomics at the sequence level. Genome Biol. 11, R121. doi: 10.1186/gb-2010-11-12-r121.
59. Saxonov, S., Berg, P., and Brutlag, D. L. (2006). A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc. Natl. Acad. Sci. U.S.A. 103, 1412-1417. doi: 10.1073/pnas.0510310103.
60. Schroeder, D. I., Lott, P., Korf, I., and LaSalle, J. M. (2011). Large-scale methylation domains mark a functional subset of neuronally expressed genes. Genome Res. 21, 1583-1591. doi: 10.1101/gr.119131.110.
61. Selamat, S. A., Chung, B. S., Girard, L., Zhang, W., Zhang, Y., Campan, M., et al. (2012). Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res. 22, 1197-1211. doi: 10.1101/gr.132662.111.
62. Shann, Y. J., Cheng, C., Chiao, C. H., Chen, D. T., Li, P. H., and Hsu, M. T. (2008). Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines. Genome Res. 18, 791-801. doi: 10.1101/gr.070961.107.
63. Sørensen, K. P., Thomassen, M., Tan, Q., Bak, M., Cold, S., Burton, M., et al. (2013). Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res. Treat. 142, 529-536. doi: 10.1007/s10549-013-2776-7.
64. Suzuki, K., Kadota, K., Sima, C. S., Nitadori, J., Rusch, V. W., Travis, W. D., et al. (2013). Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. J. Clin. Oncol. 31, 490-498. doi: 10.1200/JCO.2012.45.2052.
65. Szulwach, K. E., and Jin, P. (2014). Integrating DNA methylation dynamics into a framework for understanding epigenetic codes. Bioessays 36, 107-117. doi: 10.1002/bies.201300090.
66. Tabas-Madrid, D., Nogales-Cadenas, R., and Pascual-Montano, A. (2012). GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res. 40, W478-W483. doi: 10.1093/nar/gks402.
67. Terunuma, A., Putluri, N., Mishra, P., Mathé, E. A., Dorsey, T. H., Yi, M., et al. (2014). MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J. Clin. Invest. 124, 398-412. doi: 10.1172/JCI71180.
68. Tusher, V. G., Tibshirani, R., and Chu, G. (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 98, 5116-5121. doi: 10.1073/pnas.091062498.
69. Urosevic, J., Garcia-Albéniz, X., Planet, E., Real, S., Céspedes, M. V., Guiu, M., et al. (2014). Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH. Nat. Cell Biol. 16, 685-694. doi: 10.1038/ncb2977.
70. Vanderkraats, N. D., Hiken, J. F., Decker, K. F., and Edwards, J. R. (2013). Discovering high-resolution patterns of differential DNA methylation that correlate with gene expression changes. Nucleic Acids Res. 41, 6816-6827. doi: 10.1093/nar/gkt482.
71. Vlachos, I. S., Kostoulas, N., Vergoulis, T., Georgakilas, G., Reczko, M., Maragkakis, M., et al. (2012). DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res. 40, W498-W504. doi: 10.1093/nar/gks494.
72. Wagner, J. R., Busche, S., Ge, B., Kwan, T., Pastinen, T., and Blanchette, M. (2014). The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts. Genome Biol. 15, R37. doi: 10.1186/gb-2014-15-2-r37.
73. Wang, J., Duncan, D., Shi, Z., and Zhang, B. (2013). WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 41, W77-W83. doi: 10.1093/nar/gkt439.
74. Wang, Y., Meng, L., Hu, H., Zhang, Y., Zhao, C., Li, Q., et al. (2011). Oct-4B isoform is differentially expressed in breast cancer cells: hypermethylation of regulatory elements of Oct-4A suggests an alternative promoter and transcriptional start site for Oct-4B transcription. Biosci. Rep. 31, 109-115. doi: 10.1042/BSR20100033.
75. Wen, B., Wu, H., Loh, Y. H., Briem, E., Daley, G. Q., and Feinberg, A. P. (2012). Euchromatin islands in large heterochromatin domains are enriched for CTCF binding and differentially DNA-methylated regions. BMC Genomics 13:566. doi: 10.1186/1471-2164-13-566.
76. Wickham, H. (2009). ggplot2: Elegant Graphics for Data Analysis. New York, NY: Springer.
77. Wood, S. N. (2011). Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models. J. R. Stat. Soc. 73, 3-36. doi: 10.1111/j.1467-9868.2010.00749.x.
78. Wu, X., Gong, Y., Yue, J., Qiang, B., Yuan, J., and Peng, X. (2008). Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing. Nucleic Acids Res. 36, 3590-3599. doi: 10.1093/nar/gkn243.
79. Yu, W., Kanaan, Y., Bae, Y. K., and Gabrielson, E. (2009). Chromosomal changes in aggressive breast cancers with basal-like features. Cancer Genet. Cytogenet. 193, 29-37. doi: 10.1016/j.cancergencyto.2009.03.017.
80. Zhang, H., Niu, B., Hu, J. F., Ge, S., Wang, H., Li, T., et al. (2011). Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogates genomic imprinting of human insulin-like growth factor II. J. Cell Biol. 193, 475-487. doi: 10.1083/jcb.201101021.
81. Zheng, C., Feng, J., Lu, D., Wang, P., Xing, S., Coll, J. L., et al. (2011). A novel anti-CEACAM5 monoclonal antibody, CC4, suppresses colorectal tumor growth and enhances NK cells-mediated tumor immunity. PLoS ONE 6:e21146. doi: 10.1371/journal.pone.0021146.